Correlation of Blood FoxP3+ Regulatory T Cells and Disease Activity of Atopic Dermatitis

Overview

Journal J Immunol Res

Publisher Wiley

Specialty Allergy & Immunology

Date 2019 Oct 23

PMID 31637264

Citations 3

Authors

Yan Li

Wei Xu

Jingyi Yao

Haiyan Cheng

Xiaoli Sun

Linfeng Li

Affiliations

Soon will be listed here.

Abstract

Objectives: To investigate CD4+CD25+FoxP3+ T regulatory cells (Tregs) in the peripheral blood of patients with atopic dermatitis (AD) and its correlation with disease severity.

Methods: Blood samples from 79 AD patients before and after four-week conventional treatment were collected. Cell counts of CD4+CD25+FoxP3+Tregs, CD4+CD25+FoxP3-T effector cells (Teffs), and CD4+IL-10+Tregs were analyzed by flow cytometry. Serum levels of IL-4, IL-10, IL-12, IL-13, IFN-, and TGF- were measured by ELISA.

Results: The pretreatment cell count of CD4+CD25+FoxP3+Tregs positively correlated with disease severity in all patients ( < 0.0001). However, when that correlation was rechecked based on the treatment response, a much stronger correlation of that was found in those patients with remission after treatment, while no correlation of that was found in patients without remission. Both the cell count and proportions of peripheral CD4+CD25+FoxP3+Tregs and CD4+CD25+FoxP3-Teffs reduced significantly after treatment in patients with remission, but remained unchanged in patients without remission. The cell count and proportion of CD4+IL-10+Tregs did not change after treatment in both groups. In patients with remission, serum levels of IL-4 and IL-13 significantly reduced (all < 0.05); IL-12 and IFN- levels increased significantly (all < 0.05); IL-10 and TGF- levels remained unchanged after treatment. None of those cytokine levels changed in patients without remission.

Conclusions: CD4+CD25+FoxP3+Tregs is associated with AD development and severity in some patients but not in others. AD maybe divided into CD4+CD25+FoxP3+Treg-associated subtype, which CD4+CD25+FoxP3+Treg is parallel to the activity of AD, and nonassociated subtype, which CD4+CD25+FoxP3+Treg is not related. This subgroup difference may contribute partly to the nonidentical markers that have been found in AD and should be studied further.

Citing Articles

Relation of T Cell Profile with Vitamin D Receptor and Vitamin D-Binding Protein Gene Polymorphisms in Atopy.

Bastyte D, Tamasauskiene L, Stakaitiene I, Briede K, Ugenskiene R, Valiukeviciene S Int J Mol Sci. 2024; 25(16).

PMID: 39201708 PMC: 11354884. DOI: 10.3390/ijms25169021.

Immune Cell Profiling of Atopic Dermatitis Patients Before and After Treatment with Halometasone Cream Wet-Wrap Therapy by Single-Cell Sequencing.

Gu X, Yu X, Zhou B, Li M, Xu W, Li Y Indian J Dermatol. 2023; 68(1):8-14.

PMID: 37151231 PMC: 10162741. DOI: 10.4103/ijd.ijd_801_22.

Activated Protein C Protects against Murine Contact Dermatitis by Suppressing Protease-Activated Receptor 2.

Xue M, Lin H, Zhao R, Fryer C, March L, Jackson C Int J Mol Sci. 2022; 23(1).

PMID: 35008942 PMC: 8745259. DOI: 10.3390/ijms23010516.

References

Lesiak A, Smolewski P, Sobolewska-Sztychny D, Sysa-Jedrzejowska A, Narbutt J . The role of T-regulatory cells and Toll-like receptors 2 and 4 in atopic dermatitis. Scand J Immunol. 2012; 76(4):405-10. DOI: 10.1111/j.1365-3083.2012.02739.x. View

Nedoszytko B, Lange M, Sokolowska-Wojdylo M, Renke J, Trzonkowski P, Sobjanek M . The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part I: Treg properties and functions. Postepy Dermatol Alergol. 2017; 34(4):285-294. PMC: 5560174. DOI: 10.5114/ada.2017.69305. View

Gaspar K, Barath S, Nagy G, Mocsai G, Gyimesi E, Szodoray P . Regulatory T-cell subsets with acquired functional impairment: important indicators of disease severity in atopic dermatitis. Acta Derm Venereol. 2014; 95(2):151-5. DOI: 10.2340/00015555-1882. View

Brandt C, Pavlovic V, Radbruch A, Worm M, Baumgrass R . Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis. Allergy. 2009; 64(11):1588-96. DOI: 10.1111/j.1398-9995.2009.02054.x. View

Hauck V, Hugli P, Meli M, Rostaher A, Fischer N, Hofmann-Lehmann R . Increased numbers of FoxP3-expressing CD4+ CD25+ regulatory T cells in peripheral blood from dogs with atopic dermatitis and its correlation with disease severity. Vet Dermatol. 2016; 27(1):26-e9. DOI: 10.1111/vde.12279. View

Moosbrugger-Martinz V, Tripp C, Clausen B, Schmuth M, Dubrac S . Atopic dermatitis induces the expansion of thymus-derived regulatory T cells exhibiting a Th2-like phenotype in mice. J Cell Mol Med. 2016; 20(5):930-8. PMC: 4831369. DOI: 10.1111/jcmm.12806. View

Stelmaszczyk-Emmel A, Zawadzka-Krajewska A, Szypowska A, Kulus M, Demkow U . Frequency and activation of CD4+CD25 FoxP3+ regulatory T cells in peripheral blood from children with atopic allergy. Int Arch Allergy Immunol. 2013; 162(1):16-24. DOI: 10.1159/000350769. View

Paul W . History of interleukin-4. Cytokine. 2015; 75(1):3-7. PMC: 4532601. DOI: 10.1016/j.cyto.2015.01.038. View

Lin Y, Wang C, Chao P, Lee J, Wang L, Yu H . Skin-homing CD4+ Foxp3+ T cells exert Th2-like function after staphylococcal superantigen stimulation in atopic dermatitis patients. Clin Exp Allergy. 2011; 41(4):516-25. DOI: 10.1111/j.1365-2222.2010.03681.x. View

10.

Weiss D, Schaschinger M, Ristl R, Gruber R, Kopp T, Stingl G . Ustekinumab treatment in severe atopic dermatitis: Down-regulation of T-helper 2/22 expression. J Am Acad Dermatol. 2016; 76(1):91-97.e3. DOI: 10.1016/j.jaad.2016.07.047. View

11.

Choi Y, Lee H, Lee D, Woo S, Lee K, Yun S . Therapeutic effects and immunomodulation of suanbo mineral water therapy in a murine model of atopic dermatitis. Ann Dermatol. 2013; 25(4):462-70. PMC: 3870215. DOI: 10.5021/ad.2013.25.4.462. View

12.

Ma L, Xue H, Guan X, Shu C, Wang F, Zhang J . The Imbalance of Th17 cells and CD4(+) CD25(high) Foxp3(+) Treg cells in patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2013; 28(8):1079-86. DOI: 10.1111/jdv.12288. View

13.

Hanifin J, Thurston M, Omoto M, Cherill R, Tofte S, Graeber M . The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001; 10(1):11-8. DOI: 10.1034/j.1600-0625.2001.100102.x. View

14.

Vakirlis E, Lazaridou E, Tzellos T, Gerou S, Chatzidimitriou D, Ioannides D . Investigation of cytokine levels and their association with SCORAD index in adults with acute atopic dermatitis. J Eur Acad Dermatol Venereol. 2011; 25(4):409-16. DOI: 10.1111/j.1468-3083.2010.03800.x. View

15.

Hussein P, Zahran F, Ashour Wahba A, Ahmad A, Ibrahiem M, Shalaby S . Interleukin 10 receptor alpha subunit (IL-10RA) gene polymorphism and IL-10 serum levels in Egyptian atopic patients. J Investig Allergol Clin Immunol. 2010; 20(1):20-6. View

16.

El Samahy M, Attia E, Saad A, Mahmoud E . Circulating CD4(+) CD25(high) FoxP3(+) T-regulatory cells in patients with atopic dermatitis after narrowband-ultraviolet B phototherapy. Int J Dermatol. 2015; 54(10):e424-9. DOI: 10.1111/ijd.12801. View

17.

Samochocki Z, Alifier M, Bodera P, Jeziorkowska R, Rosiak E, Jurkiewicz B . T-regulatory cells in severe atopic dermatitis: alterations related to cytokines and other lymphocyte subpopulations. Arch Dermatol Res. 2012; 304(10):795-801. PMC: 3505524. DOI: 10.1007/s00403-012-1290-9. View

18.

Li Y, Xu W, Li L . Efficacy and Safety of Halometasone Cream to Treat Chronic Generalized Eczema and the Effects of Halometasone Cream on Serum Cortisol Levels. Biomed Res Int. 2017; 2017:3265024. PMC: 5700510. DOI: 10.1155/2017/3265024. View

19.

Ou L, Goleva E, Hall C, Leung D . T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol. 2004; 113(4):756-63. DOI: 10.1016/j.jaci.2004.01.772. View

20.

Lesiak A, Zakrzewski M, Przybylowska K, Rogowski-Tylman M, Wozniacka A, Narbutt J . Atopic dermatitis patients carrying G allele in -1082 G/A IL-10 polymorphism are predisposed to higher serum concentration of IL-10. Arch Med Sci. 2015; 10(6):1239-43. PMC: 4296079. DOI: 10.5114/aoms.2014.47833. View